Golden Age of Molecular Diagnostics
Recently, the New York Times had an article on Page 1, above the fold, titled, “Suddenly, It Looks Like We’re in a Golden Age for Medicine”. As the piece describes, the explosion of the utility of new biotech technologies, from CRISPR to mRNA, is leading to a continuous stream of new molecules targeted at an ever-expanding range of human disease. While it is inarguable that the...
Read More